Access cutting-edge ovarian cancer treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access ovarian cancer specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ovarian cancer treatment provided free
The purpose of this research study is to see if the study drug Belzutifan is effective and safe for participants with ovarian cancer. The name of the study drug involved in this study is: \- Belzutifan (a type of Hypoxia-Inducible Factor-2 alpha (HIF-2a) inhibitor)
Sponsor: Dana-Farber Cancer Institute
Check if you qualify for this ovarian cancer clinical trial in Boston, MA
If you're searching for ovarian cancer treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ovarian cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.